Riassunto Pharmanovia stipula un accordo di licenza esclusiva con Aeterna Zentaris per il primo e unico farmaco a somministrazione orale approvato per la diagnosi di deficit dellormone della crescita negli adulti
AEZSDelisted Stock | USD 6.14 0.08 1.29% |
Slightly above 61% of AEZS Old's investor base is looking to short. The analysis of current outlook of investing in AEZS Old suggests that many traders are alarmed regarding AEZS Old's prospects. AEZS Old's investing sentiment can be driven by a variety of factors including economic data, AEZS Old's earnings reports, geopolitical events, and overall market trends.
AEZS |
Pharmanovia, casa farmaceutica globale che commercializza medicinali innovativi e rivitalizza, estende ed espande il ciclo di vita dei prodotti consol
Read at businesswire.com
AEZS Old Fundamental Analysis
We analyze AEZS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AEZS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AEZS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
AEZS Old is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
AEZS Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AEZS Old stock to make a market-neutral strategy. Peer analysis of AEZS Old could also be used in its relative valuation, which is a method of valuing AEZS Old by comparing valuation metrics with similar companies.
Peers
AEZS Old Related Equities
IBIO | Ibio | 0.37 | ||||
MBRX | Moleculin Biotech | 0.56 | ||||
PULM | Pulmatrix | 4.31 | ||||
ATXI | Avenue Therapeutics | 4.62 | ||||
ADIL | Adial Pharmaceuticals | 4.67 | ||||
RNAZ | Transcode Therapeutics | 4.99 | ||||
RVPH | Reviva Pharmaceuticals | 6.50 | ||||
JAGX | Jaguar Animal | 7.63 | ||||
BPTH | Bio Path | 8.41 | ||||
TNXP | Tonix Pharmaceuticals | 10.34 | ||||
ADTX | Aditxt | 10.53 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in AEZS Stock
If you are still planning to invest in AEZS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AEZS Old's history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |